Pittman Scott M.insider trades

In SEC Form 4 filings, Pittman Scott M. is listed as Director, 10% owner of Nuo Therapeutics, Inc. (AURX). Pittman Scott M. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 6.

Companies and roles

Company	Role	Transactions	Last filed
AURXNuo Therapeutics, Inc.	Director, 10% owner	2	Oct 6

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-06

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
AURXNuo Therapeutics, Inc.	Oct 6	Oct 6	A · derivative	4,500	$1.50	$6,750	4,500	No	Form 4
AURXNuo Therapeutics, Inc.	Oct 6	Oct 6	A · derivative	458	$1.50	$687	458	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.